Form 4: ADC Therapeutics Director Victor Sandor Receives 40,000 Restricted Stock Units

Director Victor Sandor acquired 40,000 restricted stock units (RSUs) in ADC Therapeutics SA, vesting in one year, while disposing of 87,881 common shares.

Summary

• On June 13, 2024, Victor Sandor, a director of ADC Therapeutics SA, was granted 40,000 restricted stock units (RSUs) under the company's 2019 Equity Incentive Plan.
• The RSUs vest one year from the grant date, contingent upon Sandor's continued service to the Issuer.
• Each RSU represents the right to receive one share of ADC Therapeutics SA's common stock.
• Sandor also disposed of 87,881 common shares.

Sentiment

Score: 6

Explanation: The document is a standard SEC filing related to stock grants, which is neutral in sentiment. The RSU grant is a positive incentive for the director.

Positives

• The grant of RSUs aligns the director's interests with the long-term performance of the company.
• The vesting period encourages continued service and commitment from the director.

Future Outlook

The RSUs will vest one year from the grant date, subject to the Reporting Person's continued service to the Issuer.

Industry Context

Grants of restricted stock units to directors are a common practice to incentivize and retain board members, aligning their interests with those of shareholders.

Stakeholder Impact

• Shareholders may view the RSU grant as a positive incentive for the director to contribute to the company's success.

Key Dates